The "Countering Captagon and Narcotics Post-Assad Act" amends the National Defense Authorization Act for Fiscal Year 2023 to significantly modify the interagency strategy for disrupting narcotics production and trafficking in the Middle East. It broadens the scope beyond Captagon linked to the Assad regime to include methamphetamine and other amphetamine-type stimulants , particularly noting their evolving patterns following the fall of the Assad regime and their threat to regional stability and U.S. interests. The bill mandates that the interagency strategy be unclassified and include a comprehensive assessment of evolving drug production and trafficking patterns within the United States Central Command's area of responsibility. This assessment must identify countries involved in large shipments, evaluate their counter-narcotics capacities , and review current U.S. assistance and training programs. Furthermore, the strategy must assess cooperation with international partners and provide recommendations to dismantle these networks, specifically targeting those connected to the former Assad regime, Hezbollah, and Iran-backed proxies.